SCHEDULE 13G: Brandes Investment Partners Discloses 7.4% Stake in Utah Medical Products Inc.
Beneficial Ownership Report
Brandes Investment Partners, L.P. has filed a Schedule 13G, reporting beneficial ownership of 242,421 common shares, representing 7.4% of Utah Medical Products Inc.
Summary
- Brandes Investment Partners, L.P. reported beneficial ownership of 242,421 common shares of Utah Medical Products Inc. (CUSIP: 917488108).
- This ownership represents 7.4% of the total class of common shares.
- Brandes Investment Partners, L.P. holds shared voting power and shared dispositive power over all 242,421 shares.
- The filing indicates that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
Sentiment
Score: 7
Explanation: The disclosure of a significant stake by a reputable institutional investor is generally a positive signal, indicating confidence in the company. However, as a passive ownership filing, it provides no direct operational or financial performance insights.
Positives
- The disclosure of a significant stake (7.4%) by a reputable institutional investor like Brandes Investment Partners, L.P. may signal confidence in Utah Medical Products Inc.'s long-term value.
- The filing specifies that the shares are held in the ordinary course of business, indicating a passive, investment-oriented approach rather than an activist intent.
Future Outlook
This document, a Schedule 13G filing, does not contain forward-looking statements or guidance from Utah Medical Products Inc. or Brandes Investment Partners, L.P. regarding the issuer's future performance.
Industry Context
This filing reflects an institutional investor's decision to take a significant stake in a company within the medical products industry. It suggests that Brandes Investment Partners, L.P. identifies value or growth potential in Utah Medical Products Inc. or the broader medical device sector.
Stakeholder Impact
- Shareholders: The disclosure of a substantial stake by a prominent institutional investor may enhance investor confidence and potentially attract further institutional interest in Utah Medical Products Inc.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of event which requires filing of this statement |
| 05/02/2025 | Date of filing of this statement |
Keywords
Utah Medical Products Inc., Brandes Investment Partners, Schedule 13G, Beneficial Ownership, Common Shares, Institutional Investor, Medical Devices
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.